A new study in The New England Journal of Medicine, presented this weekend at the American Society of Clinical Oncology's annual conference in Chicago, found that two cancer drugs, when taken together, could shrink tumors in patients with advanced-stage melanoma.
In a trial of 945 worldwide patients, researchers found that combining ipilimumab and nivolumab, two drugs that work with the body's immune system, reduced the melanoma tumors of nearly 60 percent of patients. The combination, which spurred the immune system to fight cancer, also prevented melanoma from advancing for almost a year in more than half of the patients studied.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
NASA's Europa Clipper blasts off, seeking an oceanSpeed Read The ship is headed toward Jupiter on a yearslong journey
-
Detailed map of fly's brain holds clues to human mindSpeed Read This remarkable fruit fly brain analysis will aid in future human brain research
-
Blind people will listen to next week's total eclipseSpeed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
-
Melting polar ice is messing with global timekeepingSpeed Read Ice loss caused by climate change is slowing the Earth's rotation
-
An amphibian that produces milk?speed read Caecilians, worm-like amphibians that live underground, produce a milk-like substance for their hatchlings
-
Jupiter's Europa has less oxygen than hopedspeed read Scientists say this makes it less likely that Jupiter's moon harbors life
-
Why February 29 is a leap daySpeed Read It all started with Julius Caesar
-
US spacecraft nearing first private lunar landingSpeed Read If touchdown is successful, it will be the first U.S. mission to the moon since 1972
